ClinicalTrials.gg
Not yet recruitingNCT07823647HypnoacademicUpdated Oct 7, 2026

The Effect of Audio-hypnosis on the Academic Performance of Nursing Students.

An interventional study of Audio hypnosis in Age, Residency and Gender, sponsored by HASSAN 1st university. Not yet recruiting at 1 site in Morocco. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by HASSAN 1st university · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Sex
All
01

Study summary

Exam stress significantly affects the mental health and cognitive functions of nursing students. Audio-hypnosis offers a practical and low-cost intervention.

Objective: To evaluate the effect of a single audio-hypnosis session on perceived stress, heart rate, and academic results.

Methods: A pilot randomized trial will be conducted with 20 second-year students at ISPITS Safi, divided into an intervention group and a control group (n=10 each). Anxiety (VAS), heart rate (HR), and exam grades were analyzed.

Read the detailed description

objectives: Evaluate the effect of audio-hypnosis on stress levels and academic performance among nursing students at ISPITS in Safi.

  • Measure the stress level of nursing students before the audio-hypnosis intervention.
  • Assess the stress level of nursing students after the audio-hypnosis intervention.
  • Compare the level of stress before and after exposure to audio-hypnosis.
  • Determine the effect of audio-hypnosis on the academic performance of nursing students.
  • Analyze the relationship between stress levels and academic performance among nursing students.
  • Assess students' acceptability and satisfaction with the use of audio-hypnosis as a stress management method.

    3. Type of study: This is a pilot study in the form of a randomized controlled trial that aims to measure the impact of audio-hypnosis on stress and academic outcomes among nursing students at ISPITS de Safi.

This methodological choice is justified by several considerations:

First, the randomized controlled trial is considered to be the most rigorous method of evaluating the effectiveness of an intervention, as it allows for comparison of results between an experimental group and a control group. Secondly, the randomization of participants helps to ensure comparability between groups. Thirdly, the use of a pilot study is relevant for this research, as it allows us to assess the feasibility of audio-visual interventionhypnosis, its acceptability by nursing students as well as the practical aspects of its implementation in the context of ISPITS in Safi.

Finally, this approach will provide preliminary data on the effect of audio-hypnosis on stress and academic performance, which can form the basis for further research on a larger scale.

02

Conditions studied

  • Age
  • Residency
  • Gender
  • Stress
  • Arterial Pressure
  • HEART RATE
  • Satisfaction
  • Exam Score

Browse trials for

Keywords

  • academic performance
  • students
  • exam
  • stress
  • hypnosis
03

In context

Personal Satisfaction

541 studies on the registry are indexed under Personal Satisfaction; 93 are open to participants now.

This study's planned enrollment of 20 is below the median of 93 across 416 interventional studies indexed under Personal Satisfaction.

Browse Personal Satisfaction studies →

Lead sponsor

HASSAN 1st university is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Students enrolled in the first year of nursing training at the Higher Institute of Nursing and Health Technician Professions in Safi.
  • Volunteer students who have agreed to participate in the study and signed a free and .

Exclusion criteria

Exclusion Criteria:

  • Students who refuse to participate or do not sign consent.
  • Students who have already undergone a hypnosis session themselves.
  • Students with known psychological disorders.
  • Students with epilepsy or a history of seizures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Hypnosis group

    This arm will undergo a audio-hypnosis session before the exam.

    Behavioral: Audio hypnosis

  • No intervention
    Control group

    This group will not undergo any intervention

Interventions

  • BehavioralAudio hypnosis

    the registred audio hypnosis General script structure: 1. Introduction and preparation * Invitation to settle down comfortably * Brief explanation of the session and its objectives 2. Hypnotic induction * Slow and deep breathing techniques * Gradual focus on bodily sensations * Installation of a state of relaxation 3. In-depth study * Visualization of a quiet and secure place * Sensation of gradual relaxation of the body and mind 4. Therapeutic suggestions * Reduction of stress and negative thoughts * Building trust and self-efficacy * Activating internal resources for academic success 5. Positive projection * Self-visualization while calmly studying for a exam * To see themselves arrive at the exam with serenity and concentration 6. Exiting a trance * Gradual return to the state of arousal * Feeling of calm and lasting confidence

    Also known as: Hypnosis

06

What researchers measure

Primary outcomes

  1. exam stress

    the level of stress on the morning of the exam for both groups before the exam. For the hypnosis group, the stress level will be assessed before and after the audio-hypnosis session to measure the effect size. The stress level will be assessed with a visual analog scale (VAS) of 10 points.

    Time frame: Baseline

  2. acaedmic performance

    Academic performance: exam scores will be assessed for both groups. the score will range between 0 to 20 points

    Time frame: Baseline

Secondary outcomes

  1. Heart rate

    Heart rate before the exam: for both groups, these parameters will be evaluated in the audio-hypnosis group after the hypnosis session.

    Time frame: Baseline

  2. Satisfaction level

    the level of satisfaction with the performance of participants in the exam will be assessed at the end of the exam for both groups with a 10-point VAS scale.

    Time frame: baseline

07

Study locations

1 site
  • Safi, Marrakech-Safi Morocco
    Safi, Safi 46000, Morocco
08

References and documents

Publications

  • Ali Abdelhamid Eltrass, G., AbuBakr, O., & Elias Abdel-Aziz, A. (2022). Perceived Stress/Stressors among University Nursing Students. Egyptian Journal of Health Care, 13(4), 600-611. https://doi.org/10.21608/ejhc.2022.264204

Related links

Individual participant data

Plan to share: Yes — De-identified individual participant data that underlie the results reported in the primary publication will be available upon reasonable request. Data will be shared only after appropriate de-identification to protect participant confidentiality. The study protocol and statistical analysis plan may also be made available.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Data will be available beginning 6 months after publication of the primary study results and for a period of 5 years.

Access criteria: De-identified data will be made available to qualified researchers upon reasonable request to the corresponding author or principal investigator. Requests should include a brief research proposal describing the objectives and intended use of the data. Access will be granted following review and approval by the research team and, where applicable, subject to ethical and institutional requirements. Requesters may be required to sign a data use agreement before receiving the data.

09

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and design details
1 update, last Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Minor edits only
    + 2 other changes: verification date and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07823647
Lead sponsor
HASSAN 1st university
Responsible party
Sponsor
First posted
Sep 16, 2026
Start date
Oct 8, 2026 (estimated)
Primary completion
Oct 20, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Oct 7, 2026

Study contacts

YOUSSEF EL-ALLAM, Phd student
Contact
elallamyoussef8@gmail.com
+212653977028

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion